Electroconvulsive therapy
ELECTROCONVULSIVE THERAPY
•••Electroconvulsive therapy (ECT) is a highly efficacious treatment in psychiatry (Crowe, Abrams), and yet there is ethical controversy about its use. Some have claimed that ECT should be outlawed because it seriously impairs memory; others, that ECT is best viewed as a crude form of behavior control that psychiatrists frequently coerce patients to accept. Still others claim that, even if coercion is not employed, depressed patients are rarely, if ever, competent to give valid consent to the treatment (Breggin). The complaint is also sometimes voiced that ECT is given more frequently to women patients than to men. There is also ample evidence that, in earlier years, ECT was given in ways that are not used today: higher amounts of electrical current, and sometimes daily or several-times-daily treatments. Undoubtedly, this harmed some patients (Breggin). Probably because of concerns like these, one state, California, has passed legislation making it difficult for psychiatrists to employ ECT without satisfying many administrative regulations (California Welfare and Institutions Code). There also exist several activist groups that are opposed to all ECT and have even tried to criminalize the administration of ECT. Daniel Smith provides an excellent summary of these groups's arguments and activities in his 2001 article "Shock and Disbelief."
The nature of the treatment itself understandably frightens some persons, and there have been gruesome depictions of it in popular films and novels (Kesey). The notion of passing an electrical current through the brain, stimulating a cerebral seizure and causing unconsciousness, may seem forbidding, particularly in view of the fact that ECT's therapeutic mechanism of action remains largely unknown. There are, however, many effective treatments in medicine whose mechanisms are unknown, and there are probably many surgical treatments that would seem equally forbidding if they were observed by a layperson. In appraising the ethical legitimacy of ECT as a treatment, it is important to ask the same questions about ECT that are asked about any treatment: Of what does it consist, what is the likelihood that it will help, what kinds of harm can it cause; and how does its spectrum of benefits and harms compare with those of alternative plausible treatments?
ECT Treatment
There are several excellent reviews of the history, clinical indications, and likely harms and benefits of ECT (Abrams; American Psychiatric Association Task Force on Electroconvulsive Therapy (APA Task Force); Crowe; Ottosson). The essential feature of the treatment is the induction of a cerebral seizure (which is easily measured via concomitant electroencephalography) by means of electrodes attached to the scalp. Current is applied through the electrodes for a fraction of a second. The two electrodes may be attached to the right and left temples (bilateral ECT), inducing a seizure in both hemispheres of the brain, or to anterior and posterior placements on only one side (unilateral ECT), limiting the seizure to that side. Patients are premedicated with a muscle relaxant and anesthetized with a short-acting barbiturate general anesthetic. Patients remain unconscious after the treatment for about five minutes and are usually mildly confused for an hour or so after they awaken. They have no memory of the treatment itself. Treatments are usually given two or three times weekly for two to four weeks.
ECT was used originally as a treatment for schizophrenia on the basis of the now-discredited belief that epilepsy, which ECT was thought to mimic, and schizophrenia did not occur in the same persons. It is used chiefly with patients suffering from severe depression; most psychiatrists suggest its use to patients only when drug treatment and/or psychotherapy have not helped. ECT is also used occasionally with bipolar patients suffering from a life-threatening degree of manic excitement, or to schizophrenic patients suffering from a catatonic stupor, when these conditions do not improve with drug therapy.
Efficacy and Side Effects
The effectiveness of ECT in reversing severe depression seems beyond dispute (Abrams; Crowe; APA Task Force): Many large studies show a significant recovery from depression in 80 to 90 percent of patients who receive ECT, as compared with 50 to 60 percent of depressed patients who respond to antidepressant medication. Patients who do not respond to drugs show a high response rate to ECT: about 50 to 60 percent recover. No study comparing the differential effects of drugs and ECT has ever found that drugs have a greater therapeutic effect. ECT also works more quickly than drugs: Patients who improve typically begin to do so after about one week; drugs, if they work, typically take three to four weeks, sometimes longer, to have a significant effect. Many studies have shown that unilateral and bilateral ECT are equally effective treatments, although a minority have found unilateral ECT to be on average less effective. However unilateral ECT also causes, on average, less cognitive confusion during treatment and less residual memory impairment afterward.
Although ECT can cause death, it does so infrequently that it is difficult to reliably estimate a mortality rate. The largest modern report (Heshe and Roeder) studied 3,438 courses of treatment (22,210 ECTs), and only one death occurred. The APA Task Force estimates a death rate of 1 in 10,000 patients and 1 in 80,000 treatments. When ECT does cause death, it is usually cardiovascular in origin and is related to the use of a general barbiturate anesthesia.
The principal adverse effect of ECT on some patients is to cause one or another kind of memory impairment. Two of these kinds of memory impairment are limited. During the two to three weeks that treatments are given, memory and other cognitive functions are usually mildly to moderately impaired because of the ongoing seizures. Moreover in later years patients are often unable to recall many events that took place shortly before, during, and shortly after the two- to three-week course of treatment. Neither of these effects bothers most patients, as long as they understand ahead of time that they will occur.
The more important and controversial question is how often ECT causes an ongoing, permanent deficit in memory function (an anterograde amnesia). If and when it does, it is possible that the treatment has damaged parts of the brain underlying memory function. This has proven to be an elusive research problem, despite dozens of studies, many quite sophisticated, that have been carried out (Taylor et al., Abrams). Among the many methodological problems involved in doing this research (Strayhorn) is the fact that depression itself often causes cognitive impairment, including memory dysfunction. In fact studies of the effect of ECT on memory have repeatedly shown that the majority of patients actually report improved memory function after ECT, probably due to the diminution of their depression (APA Task Force).
A small minority of patients—the exact percentage seems unknown—do report mild, ongoing, permanent memory problems after ECT; nearly all of them rate the memory problem as annoying but not serious. However, when patients treated with ECT are compared with appropriate control groups, no deterioration in performance on objective tests of memory ability has ever been found. Nonetheless a very small number of patients, perhaps 1 to 2 percent, complain of serious ongoing memory problems. Memory complaints occur more frequently after bilateral than unilateral ECT, which has led many commentators to recommend that unilateral treatment generally be given, and that bilateral treatment be used only in serious conditions and after unilateral ECT has failed.
Ethical Issues
Is ECT so harmful that it should be outlawed? Very few persons maintain this position. ECT has an extremely small risk of causing death. It probably also has a small risk of causing chronic mild memory impairment, and a very small risk of causing chronic serious memory impairment. It is frequently used, however, in clinical settings where other treatments have failed and where the patient is suffering intensely and may be at risk of dying. Severe depression is a miserable and a serious illness: The three-year death rate in untreated or undertreated patients is about 10 percent, while in treated patients, it is about 2 percent (Avery and Winokur). Even if the risks of ECT were substantially greater than they are, it would still be rational in the clinical setting of severe depression for patients to consent to receiving ECT.
As with all other treatments in medicine, the possible harms and benefits of ECT should be explained to the patient during the consent process. The risk of death and of chronic memory dysfunction should be mentioned specifically. The APA Task Force also stipulates that a discussion should be included, during the consent process, "of the relative merits and risks of the different stimulus electrode placements and the specific choice that has been made for the patient. The patient's understanding of the data presented should be appraised, questions should be encouraged, and ample time for decision making should be allowed. Patients should be free to change their minds about receiving ECT, either before the treatments start or once they are under way" (pp. 5–6).
ECT is often suggested to patients only after other treatments have failed. However, although it has slight risks, ECT has several advantages over other treatments: It works more quickly, in a higher percentage of cases, and it does not have the annoying and, for some cardiac patients, possibly dangerous side effects of many antidepressant drugs. Following the general notion that part of an adequate valid consent process is to inform patients of any available rational treatment options (Gert et al.), a strong argument can be made that, from the outset of treatment, seriously depressed patients should be offered ECT as one therapeutic option (Culver et al.). The APA Task Force states: "As a major treatment in psychiatry with well-defined indications, ECT should not be reserved for use only as a last resort."
Do psychiatrists often coerce patients into receiving ECT? This seems doubtful, but there are no data addressing this question. In the overwhelming majority of cases, psychiatrists should not force any treatment on a patient. Nonetheless there are very rare clinical situations in which it is ethically justified to give ECT to patients who refuse it (Group for the Advancement of Psychiatry): for example, patients in danger of dying from a severe depression that has not been responsive to other forms of treatment (Merskey). But this is a special instance of the general ethical issue of justified paternalistic treatment, and no special rules should apply to psychiatric patients or to ECT (Gert et al.).
There seems no reason to believe that the consent or the refusal depressed patients give to undergo ECT is not in most cases valid. If a patient is given adequate information about the treatment, if he or she understands and appreciates this information, and if the patient's choice is not forced, then the decision is valid and, in almost all cases, should be respected. Most psychiatrists would assert that the great majority of depressed patients are like the great majority of all patients: They feel bad, they would like to feel better, and if presented with information about available treatment options, they try to make a rational choice.
Is ECT disproportionally and unjustly given to women patients? There are no data that address this question, and it would be useful to obtain them. However, given the fact that women suffer from clinically significant depression two to three times more frequently than men (Willner), the critical question is not whether more women in total receive ECT, as would be expected, but whether ECT is given at a higher rate to women than to equally depressed men.
charles m. culver (1995)
revised by author
SEE ALSO: Behaviorism; Behavior Modification Therapies; Electrical Stimulation of the Brain; Emotions; Freedom and Free Will; Human Dignity; Informed Consent: Issues of Consent in Mental Healthcare; Mental Health Therapies; Mental Illness: Issues in Diagnosis; Neuroethics; Psychiatry, Abuses of; Psychosurgery, Ethical Aspects of; Psychosurgery, Medical and Historical Aspects of; Research Policy: Risk and Vulnerable Groups; Technology
BIBLIOGRAPHY
Abrams, Richard. 2002. Electroconvulsive Therapy, 4th edition. New York: Oxford.
American Psychiatric Association. Task Force on Electroconvulsive Therapy. 2001. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging, 2nd edition. Washington, D.C.: Author.
Avery, David, and Winokur, George. 1976. "Mortality in Depressed Patients Treated with Electroconvulsive Therapy and Antidepressants." Archives of General Psychiatry 33(9): 1029–1037.
Breggin, Peter Roger. 1979. Electroshock: Its Brain-Disabling Effects. New York: Springer.
California Welfare and Institutions Code. 1979. §§5325.1, 5326.7, 5326.8, 5434.2.
Crowe, Raymond R. 1984. "Electroconvulsive Therapy—A Current Perspective." New England Journal of Medicine 311(3): 163–167.
Culver, Charles M.; Ferrell, Richard B.; and Green, Ronald M. 1980. "ECT and Special Problems of Informed Consent." American Journal of Psychiatry 137: 586–591.
Gert, Bernard; Culver, Charles M.; and Clouser, K. Danner. 1997. Bioethics: A Return to Fundamentals. New York: Oxford.
Group for the Advancement of Psychiatry. Committee on Medical Education. 1990. A Casebook in Psychiatric Ethics. New York: Brunner/Mazel.
Heshe, Joergen, and Roeder, Erick. 1976. "Electroconvulsive Therapy in Denmark." British Journal of Psychiatry 128: 241–245.
Kesey, Ken. 1962. One Flew over the Cuckoo's Nest. New York: New American Library.
Merskey, Harold. 1991. "Ethical Aspects of the Physical Manipulation of the Brain." In Psychiatric Ethics, 3rd edition, ed. Sidney Bloch and Paul Chodoff. Oxford: Oxford University Press.
Ottosson, Jan-Otto. 1985. "Use and Misuse of Electroconvulsive Treatment." Biological Psychiatry 20(9): 933–946.
Smith, Daniel. 2001. "Shock and Disbelief." Atlantic 287(2): 79–90.
Strayhorn, Joseph M., Jr. 1982. Foundations of Clinical Psychiatry. Chicago: Year Book Medical Publishers.
Taylor, John R.; Tompkins, Rachel; Demers, Renée; and Anderson, Dale. 1982. "Electroconvulsive Therapy and Memory Dysfunction: Is There Evidence for Prolonged Defects?" Biological Psychiatry 17(10): 1169–1193.
Willner, Paul. 1985. Depression: A Psychobiological Synthesis. New York: Wiley.
